Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DEMAE-CAN, First Half Ordinary Profit Loss Narrows, Dec-Feb Ordinary Profit Loss Narrows
2484 DEMAE-CAN CO.,LTD. 【J-GAAP】
Earnings ReportDEMAE-CAN CO.,LTD. <2484> [TSE Std] announced its financial results after the market closed on April 14th (15:30). The consolidated ordinary loss for the cumulative second quarter of the fiscal year ending August 2025 (September 2024 to February 2025) was a reduced loss of 1.33 billion yen (compared to a loss of 4.31 billion yen in the same period last year).
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the March to August period (2H) is expected to turn into a profit of 1.35 billion yen (compared to a loss of 1.54 billion yen in the same period last year).
In the most recent three-month period, from December to February (2Q), the consolidated ordinary loss improved to a deficit of 0.87 billion yen (compared to a loss of 3.1 billion yen in the same period last year). The operating profit/loss margin drastically improved from -23.3% in the same period last year to -9.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Feb, 2022 | 25,386 | -8,739 | -8,687 | -8,715 | -66.2 | ー | Apr 12, 2023 | J-GAAP |
Sep - Feb, 2023 | 25,551 | -4,394 | -4,310 | -4,240 | -32.1 | ー | Apr 15, 2024 | J-GAAP |
Sep - Feb, 2024 | 20,873 | -1,286 | -1,338 | -1,344 | -11.6 | ー | Apr 14, 2025 | J-GAAP |
YoY | -18.3% | +70.7% | +69.0% | +68.3% | +64.0% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Feb, 2024 Guidance | ー | ー | ー | ー | - | 0 | Oct 11, 2024 | J-GAAP |
Sep - Feb, 2024 Results | 20,873 | -1,286 | -1,338 | -1,344 | -11.6 | 0 | Apr 14, 2025 | J-GAAP |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 24,860 | -1,597 | -1,543 | 535 | 4.1 | 0 | Oct 11, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | 32,127 | 1,287 | 1,351 | 1,345 | 13.5 | 0 | Apr 14, 2025 | J-GAAP |
YoY | +29.2% | - | - | +151.4% | +230.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Aug, 2023 | 51,416 | -12,259 | -12,122 | -12,154 | -92.3 | 0 | Oct 13, 2023 | J-GAAP |
Aug, 2024 | 50,411 | -5,991 | -5,853 | -3,705 | -28.2 | 0 | Oct 11, 2024 | J-GAAP |
Aug, 2025 Guidance | 53,000 | 1 | 13 | 1 | 0.0 | 0 | Oct 11, 2024 | J-GAAP |
YoY | +5.1% | - | - | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 13,444 | -3,138 | -3,101 | -3,029 | -22.9 | -23.3 | Apr 15, 2024 | J-GAAP |
Mar - May, 2024 | 12,563 | -804 | -746 | -806 | -6.1 | -6.4 | Jul 12, 2024 | J-GAAP |
Jun - Aug, 2024 | 12,297 | -793 | -797 | 1,341 | 10.2 | -6.4 | Oct 11, 2024 | J-GAAP |
Sep - Nov, 2024 | 11,048 | -400 | -462 | -465 | -3.9 | -3.6 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 9,825 | -886 | -876 | -879 | -7.6 | -9.0 | Apr 14, 2025 | J-GAAP |
YoY | -26.9% | +71.8% | +71.8% | +71.0% | +67.0% |
Related Articles
GDEP ADVANCE, The Current Fiscal Year Ordinary Profit Revised Upward by 16%, Raises Record High Profit Forecast, Dividend Revised Upward by 5.5 yen
NISSO PRONITY, First Half Ordinary Profit Increases by 4%, Current Fiscal Year Dividend Revised Upward by 10 yen
Lacto Japan, Dec-Feb (1Q) Ordinary Profit Increases by 43%
SMN, Last Fiscal Year Net Income Revised Upward by 93%
DOUTOR NICHIRES, 12% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 4 yen
Copa Corp, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Net Income to Narrow
STUDIO ALICE, 6% Decrease in Ordinary Profit for The Current Fiscal Year
COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%
FP Partner, Dec-Feb (1Q) Ordinary Profit Decreases by 42%
DIP, 10% Decrease in Ordinary Profit for The Current Fiscal Year